AG Barr Stock (OTC:BAGFF), Trade Ideas

AG Barr PLC manufacture, distribute and sell a range of beverages in the United Kingdom. It distributes its products to wholesalers and retailers. The company's brands include Irn-Bru, Rubicon, Strathmore, and Funkin. It operates in three business segments which include Soft drinks, Cocktail solutions, and others. The majority of sales come from the soft drinks segment, which includes two business units, Barr Soft Drinks, and Boost Drinks. Geographically it generates key revenue from the United Kingdom.

AG Barr PLC

News

Guidance

Kimberley-Clark Boosts FY24 Adj EPS Outlook To low-Teens Percentage Rate Growth From High-Single-Digit Growth

Earnings

Health Care

General

OPCH

Option Care Health Sees FY2024 Adjusted EBITDA Of $430M-$450M Versus Prior Guidance Of $425M-$450M

Option Care Health Expects FY24 Net Revenue Of $4.65B-$4.8B Versus Prior Guidance Of $4.6B-$4.8B Vs $4.71B Est.

Kimberley- Clark Updates FY24 Organic Net Sales Growth Outlook To Mid-Single Digits From The Previous Low-To Mid-Single-Digit

<table cellspacing="0">
<tbody>
<tr>
<td colspan="1" rowspan="1">
Full-Year Forecast
</td>
</tr>
</tbody>
</table>
<table cellspacing="0">
<tbody>
<tr>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="9" rowspan="1">
Full-Year
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="3" rowspan="1">
2024
Forecast
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
2023
</td>
<td colspan="3" rowspan="1">
Growth
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
Reported Diluted EPS
</td>
<td colspan="1" rowspan="1">
$5.70
</td>
<td colspan="1" rowspan="1">
-
</td>
<td colspan="1" rowspan="1">
$5.82
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
$ 5.02
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
Adjustments:
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
Asset impairment and exit costs(1)
</td>
<td colspan="3" rowspan="1">
0.09
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
0.06
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
Termination of distribution arrangement in the Middle East
</td>
<td colspan="3" rowspan="1">
&mdash;
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
0.04
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
Impairment of goodwill and other intangibles
</td>
<td colspan="3" rowspan="1">
0.01
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
0.44
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
Amortization of intangibles(2)
</td>
<td colspan="3" rowspan="1">
0.43
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
0.25
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
Charges related to the war in Ukraine
</td>
<td colspan="3" rowspan="1">
&mdash;
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
0.03
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
Swedish Match AB acquisition accounting related items
</td>
<td colspan="3" rowspan="1">
&mdash;
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
0.01
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
Income tax impact associated with Swedish Match AB financing
</td>
<td colspan="3" rowspan="1">
0.07
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
(0.11)
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
South Korea indirect tax charge
</td>
<td colspan="3" rowspan="1">
&mdash;
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
0.11
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
Termination of agreement with Foundation for a Smoke-Free World
</td>
<td colspan="3" rowspan="1">
&mdash;
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
0.07
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
Fair value adjustment for equity security investments
</td>
<td colspan="3" rowspan="1">
(0.08)
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
(0.02)
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
Tax items
</td>
<td colspan="3" rowspan="1">
(0.03)
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
0.11
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
Total Adjustments
</td>
<td colspan="3" rowspan="1">
0.49
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
0.99
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
Adjusted Diluted EPS
</td>
<td colspan="1" rowspan="1">
$6.19
</td>
<td colspan="1" rowspan="1">
-
</td>
<td colspan="1" rowspan="1">
$6.31
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
$ 6.01
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
Less: Currency
</td>
<td colspan="3" rowspan="1">
(0.36)
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
Adjusted Diluted EPS, excluding currency
</td>
<td colspan="1" rowspan="1">
$6.55
</td>
<td colspan="1" rowspan="1">
-
</td>
<td colspan="1" rowspan="1">
$6.67
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
$ 6.01
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
9.0%
</td>
<td colspan="1" rowspan="1">
-
</td>
<td colspan="1" rowspan="1">
11.0%
</td>
</tr>
</tbody>
</table>

Philip Morris Intl FY24 Adj. EPS Outlook  $6.19-$6.31 Vs. $6.37 Estimate, Q2 Adj. EPS Outlook $1.50-$1.55 Vs. $1.63 Estimate

Kimberly-Clark (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMB#NYSE">KMB</a>) reported quarterly adjusted earnings of $2.01 per share which beat the analyst consensus estimate of $1.63 by 23.31 percent. This is a 20.36 percent increase over earnings of $1.67 per share from the same period last year. The company reported quarterly sales of $5.15 billion which beat the analyst consensus estimate of $5.09 billion by 1.16 percent. This is a 0.89 percent decrease over sales of $5.20 billion the same period last year.

Earnings Beats

Kimberly-Clark Q1 Adj $2.01 Beats $1.63 Estimate, Sales $5.15B Beat $5.09B Estimate

Fiserv (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FI#NYSE">FI</a>) reported quarterly earnings of $1.88 per share which beat the analyst consensus estimate of $1.79 by 5.03 percent. This is a 18.99 percent increase over earnings of $1.58 per share from the same period last year. The company reported quarterly sales of $4.883 billion which beat the analyst consensus estimate of $4.575 billion by 6.74 percent. This is a 7.39 percent increase over sales of $4.547 billion the same period last year.

Fiserv Q1 2024 Adj EPS $1.88 Beats $1.79 Estimate, Sales $4.883B Beat $4.575B Estimate

Option Care Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OPCH#NASDAQ">OPCH</a>) reported quarterly earnings of $0.26 per share which beat the analyst consensus estimate of $0.23 by 13.04 percent. This is a 23.81 percent increase over earnings of $0.21 per share from the same period last year. The company reported quarterly sales of $1.146 billion which beat the analyst consensus estimate of $1.102 billion by 4.02 percent. This is a 12.82 percent increase over sales of $1.016 billion the same period last year.

Option Care Health Q1 2024 GAAP EPS $0.26 Beats $0.23 Estimate, Sales $1.146B Beat $1.102B Estimate

Pentair Sees Q2 Adj EPS Of $1.15 - $1.17 Vs. $1.16 Est.

WIIM

Sherwin-Williams shares are trading lower following worse-than-expected Q1 earnings.

Ryder Sees Q2 Adj EPS Of $2.75-$2.95, Est $2.83

Sherwin-Williams Reaffirms 2024 Adj. EPS Guidance $10.85-$11.35 vs $11.44 Est.

Community Bank System (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CBU#NYSE">CBU</a>) reported quarterly earnings of $0.82 per share which beat the analyst consensus estimate of $0.78 by 5.13 percent. The company reported quarterly sales of $177.275 million which beat the analyst consensus estimate of $176.833 million by 0.25 percent. This is a 42.36 percent increase over sales of $124.525 million the same period last year.

Community Bank System Q1 2024 Adj EPS $0.82 Beats $0.78 Estimate, Sales $177.275M Beat $176.833M Estimate

Pentair Sees FY24 Adj EPS Of $4.15 - $4.25 Vs. $4.2 Est.

Ryder Chief Financial Officer John Diez, said,&nbsp;&quot;We are raising the lower end of our full-year forecast to reflect the outperformance in the quarter, partially offset by a more modest rental upturn than initially expected. We are also raising our free cash flow forecast and reducing our rental capital spending forecast by&nbsp;$100 million&nbsp;to align with this revised&nbsp;outlook.&quot;

Ryder Cuts Full Year 2024 Total Revenue Growth Outlook From ~13% To ~10%; Revises Adj EPS Outlook From $11.50-$12.50 To $11.75-$12.50, Est $11.70

Sherwin-Williams (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHW#NYSE">SHW</a>) reported quarterly earnings of $2.17 per share which missed the analyst consensus estimate of $2.21 by 1.81 percent. The company reported quarterly sales of $5.370 billion which missed the analyst consensus estimate of $5.505 billion by 2.46 percent. This is a 1.32 percent decrease over sales of $5.442 billion the same period last year.

Earnings Misses

Sherwin-Williams Q1 2024 Adj EPS $2.17 Misses $2.21 Estimate, Sales $5.370B Miss $5.505B Estimate

Philip Morris Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PM#NYSE">PM</a>) reported quarterly earnings of $1.50 per share which beat the analyst consensus estimate of $1.41 by 6.38 percent. This is a 8.7 percent increase over earnings of $1.38 per share from the same period last year. The company reported quarterly sales of $8.793 billion which beat the analyst consensus estimate of $8.468 billion by 3.84 percent. This is a 9.65 percent increase over sales of $8.019 billion the same period last year.

Philip Morris Intl Q1 2024 Adj EPS $1.50 Beats $1.41 Estimate, Sales $8.793B Beat $8.468B Estimate

Invesco (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IVZ#NYSE">IVZ</a>) reported quarterly earnings of $0.33 per share which missed the analyst consensus estimate of $0.40 by 17.5 percent. The company reported quarterly sales of $1.05 billion which missed the analyst consensus estimate of $1.09 billion by 3.32 percent. This is a 2.14 percent decrease over sales of $1.08 billion the same period last year.

Invesco Q1 2024 Adj EPS $0.33 Misses $0.40 Estimate, Sales $1.05B Miss $1.09B Estimate

eaffirms outlook for full year 2024
<ul>
<li>Sales of $78.0 - $79.0 billion</li>
<li>Adjusted EPS&#x2A; of $5.25 - $5.40</li>
<li>Free cash flow&#x2A; of approximately $5.7 billion</li>
</ul>

RTX Reaffirms FY24 Outlook: Revenue $78B-$79B Vs. $78.78B Estimate, Adjusted EPS of $5.25 - $5.40 Vs. $5.39 Estimate

Pentair (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PNR#NYSE">PNR</a>) reported quarterly adjusted earnings of $0.94 per share which beat the analyst consensus estimate of $0.90 by 4.44 percent. This is a 3.3 percent increase over earnings of $0.91 per share from the same period last year. The company reported quarterly sales of $1.02 billion which beat the analyst consensus estimate of $1.01 billion by 0.69 percent. This is a 1.17 percent decrease over sales of $1.03 billion the same period last year.